Business Description
Founded in 1998 and headquartered in Namyangju-si, South Korea, HLB Pharmaceutical Co. Ltd. is a drug research and development company formerly known as Mediforum Pharmaceutical Incorporation. The company produces a broad range of pharmaceutical products spanning numerous therapeutic areas, from pain relief and antibiotics to dermatology and cardiovascular care. It is also advancing CTT-004, an experimental treatment for ataxia caused by spinocerebellar degeneration, while providing contract manufacturing services to outside clients.
